KFS
ABBV icon

Kaizen Financial Strategies’s AbbVie ABBV Stock Holding History

Kaizen Financial Strategies’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Buy
4,092
+40
+1% +$8.61K 0.33% 55
2026
Q1 		$847K Sell
4,052
-87
-2% -$19.3K 0.36% 51
2025
Q4 		$946K Buy
4,139
+81
+2% +$18.5K 0.42% 42
2025
Q3 		$889K Sell
4,058
-304
-7% -$61.9K 0.4% 47
2025
Q2 		$810K Buy
4,362
+162
+4% +$30.1K 0.41% 44
2025
Q1 		$880K Buy
4,200
+200
+5% +$38.9K 0.51% 33
2024
Q4 		$711K Buy
4,000
+6
+0.2% +$1.1K 0.4% 42
2024
Q3 		$789K Buy
3,994
+17
+0.4% +$3.17K 0.46% 39
2024
Q2 		$743K Buy
3,977
+621
+19% +$103K 0.46% 37
2024
Q1 		$611K Buy
3,356
+359
+12% +$61.9K 0.41% 44
2023
Q4 		$464K Buy
2,997
+373
+14% +$54.4K 0.35% 52
2023
Q3 		$391K Sell
2,624
-229
-8% -$33.6K 0.33% 51
2023
Q2 		$385K Sell
2,853
-23
-0.8% -$3.37K 0.33% 57
2023
Q1 		$458K Buy
2,876
+3
+0.1% +$459 0.45% 42
2022
Q4 		$441K Buy
2,873
+2
+0.1% +$307 0.44% 51
2022
Q3 		$385K Sell
2,871
-94
-3% -$13.5K 0.39% 64
2022
Q2 		$454K Buy
2,965
+19
+0.6% +$2.9K 0.45% 59
2022
Q1 		$478K Sell
2,946
-176
-6% -$25.6K 0.37% 65
2021
Q4 		$423K Sell
3,122
-399
-11% -$47.1K 0.32% 84
2021
Q3 		$380K Buy
+3,521
New +$402K 0.31% 83
2021
Q1 		$391K Sell
3,610
-3,249
-47% -$348K 0.37% 79
2020
Q4 		$735K Buy
+6,859
New +$659K 0.82% 34

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Kaizen Financial Strategies's ABBV Position: Q2 2026 in Review

Kaizen Financial Strategies increased its AbbVie (ABBV) stake by 0.99% in Q2 2026, buying an estimated $8.61K and bringing the position to 4,092 shares worth $1.03M. The position accounts for 0.33% of the portfolio, ranked #55.

Kaizen Financial Strategies first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. 2,030 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Kaizen Financial Strategies held 4,092 shares of AbbVie worth $1.03M as of Q2 2026.
  • Kaizen Financial Strategies bought 40 AbbVie shares in Q2 2026, an estimated $8.61K.
  • AbbVie made up 0.33% of Kaizen Financial Strategies's portfolio in Q2 2026, its #55 holding.
  • Kaizen Financial Strategies first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
  • 2,030 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Kaizen Financial Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.